BIO.B — Bio Rad Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual balance sheet for Bio Rad Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,115	991	870	1,791	1,607
Net Total Accounts Receivable
Net Total Receivables	393	419	424	495	489
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,180	2,140	1,990	3,158	3,048
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	701	694	716	680	724
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	8,009	12,973	17,799	13,502	12,299
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	905	632	681	569	523
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	2,254	3,093	4,114	3,886	3,558
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,755	9,880	13,685	9,615	8,741
Total Liabilities & Shareholders' Equity	8,009	12,973	17,799	13,502	12,299
Total Common Shares Outstanding